63388 Federal Register / Vol. 69, No. 210 / Monday, November 1, 2004 / Notices 

Project Purpose, Historical 

Background, and Description: The U.S. 

Department of Homeland Security is 

currently located in the existing Peace 

Arch Port of Entry facility. The existing 

facility does not currently meet the 

tenant agencies space or mission 

requirements. The existing facility 

cannot be adapted to accommodate the 

required space needs of the agency 

tenants. 

Alternatives: The EIS will examine 

the short- and long-term impacts on the 

natural and physical environment. The 

impact assessment will include but not 

be limited to impacts such as social 

environment, changes in land use, 

aesthetics, changes in adjacent park 

land, changes in traffic patterns and 

access to the ‘‘D’’ street intersection, 

economic impacts, and consideration of 

City planning and zoning requirements. 

The EIS will examine measures to 

mitigate significant adverse impacts 

resulting from the proposed action. 

Concurrent with NEPA implementation, 

GSA will also implement its 

consultation responsibilities under 

section 106 of the National Historical 

Preservation Act to identify potential 

impacts to existing historic or cultural 

resources. 

The EIS will consider a no-action 

alternative and action alternatives. The 

no-action alternative would continue 

the occupancy in the existing Peace 

Arch Port of Entry facility in Blaine. The 

action alternatives will consist of three 

different configurations for construction 

of a new Port of Entry facility. 

ADDRESSES: In addition to the public 

scoping process, you may send written 

comments on the scope of alternatives 

and potential impacts to the following 

address: Michael D. Levine, Regional 

Environmental Program Analyst, 

10PDTB, General Services 

Administration, 400 15th Street SW., 

Auburn, WA, 98001, or fax: Michael D. 

Levine at 253–931–7308, or e-mail at 

Michael.Levine@GSA. GOV. Written 

comments should be received no later 

than 45 days after the publishing of this 

notice.

FOR FURTHER INFORMATION CONTACT: John 

Meerscheidt at Herrera Environmental 

Consultants, 2200 Sixth Ave., Suite 601, 

Seattle, Washington 98121 or call 206–

441–9080; or Michael D. Levine, GSA 

(253) 931–7263. 

MAILING LIST: If you wish to be placed 

on the project mailing list to receive 

further information as the EIS process 

develops, contact John Meerscheidt at 

the address noted above.

Dated: October 15, 2004. 

William L. Dubray, 

Executive Director (10A).

[FR Doc. 04–24330 Filed 10–29–04; 8:45 am] 

BILLING CODE 6820–23–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Advisory Commission on Childhood 

Vaccines; Notice of Meeting 

In accordance with section 10(a) (2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), notice is hereby given 

of the following meeting:

Name: Advisory Commission on 

Childhood Vaccines (ACCV). 

Date and Time: November 10, 2004, 9 

a.m.–2:30 p.m., e.d.t. 

Place: Audio Conference Call and 

Parklawn Building, Conference Rooms G & H, 

5600 Fishers Lane, Rockville, MD 20857. 

The full ACCV will meet on Wednesday, 

November 10, from 9 a.m. to 2:30 p.m. The 

public can join the meeting in person at the 

address listed above or by audio conference 

call by dialing 1–888–730–9135 on 

November 10 and providing the following 

information: 

Leader’s Name: Joyce Somsak. 

Password: ACCV. 

Agenda: The agenda items for November 

will include, but are not limited to: An 

update on changing the Vaccine Injury Table; 

an overview of the National Vaccine Program 

Office’s Public Participating Workgroup 

Meeting: Meeting on Models for Enhancing 

Public Involvement; and updates from the 

Division of Vaccine Injury Compensation, the 

Department of Justice, and the National 

Vaccine Program Office. Agenda items are 

subject to change as priorities dictate. 

Public Comments: Persons interested in 

providing an oral presentation should submit 

a written request, along with a copy of their 

presentation to: Ms. Cheryl Lee, Principal 

Staff Liaison, Division of Vaccine Injury 

Compensation, Healthcare Systems Bureau, 

Health Resources and Services 

Administration, Room 11C–26, 5600 Fishers 

Lane, Rockville, MD 20857 or e-mail 

clee@hrsa.gov. Requests should contain the 

name, address, telephone number, and any 

business or professional affiliation of the 

person desiring to make an oral presentation. 

Groups having similar interests are requested 

to combine their comments and present them 

through a single representative. The 

allocation of time may be adjusted to 

accommodate the level of expressed interest. 

The Division of Vaccine Injury Compensation 

will notify each presenter by mail or 

telephone of their assigned presentation time. 

Persons who do not file an advance request 

for a presentation, but desire to make an oral 

statement, may announce it at the time of the 

comment period. These persons will be 

allocated time as time permits.

FOR FURTHER INFORMATION CONTACT:

Anyone requiring information regarding 

the ACCV should contact Ms. Cheryl 

Lee, Principal Staff Liaison, Division of 

Vaccine Injury Compensation, 

Healthcare Systems Bureau, Health 

Resources and Services Administration, 

Room 11C–26, 5600 Fishers Lane, 

Rockville, Maryland 20857; telephone 

(301) 443–2124 or e-mail clee@hrsa.gov.

Dated: October 26, 2004. 

Tina M. Cheatham, 

Director, Division of Policy Review and 

Coordination.

[FR Doc. 04–24307 Filed 10–29–04; 8:45 am] 

BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–04–04JJ] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 498–1210 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Human 

Resources and Housing Branch, New 

Executive Office Building, Room 10235, 

Washington, DC 20503 or by fax to (202) 

395–6974. Written comments should be 

received within 30 days of this notice. 

Proposed Project 

Evaluation of Efficacy of Household 

Water Filtration/Treatment Devices in 

Households with Private Wells—New—

National Center for Environmental 

Health (NCEH), Centers for Disease 

Control and Prevention (CDC). 

Approximately 42.4 million people in 

the United States are served by private 

wells. Unlike community water systems, 

private wells are not regulated by the 

U.S. Environmental Protection Agency’s 

(EPA) Safe Drinking Water Act (SDWA). 

Under the SDWA, EPA sets maximum 

contaminant levels (MCLs) for 

contaminants in drinking water. A 1997 

U.S. General Accounting Office (GAO) 

report on drinking water concluded that 

users of private wells may face higher 

exposure levels to groundwater 

contaminants than users of community 

water systems. Increasingly, the public 

is concerned about drinking water